Senior Business Development Search & Evaluation Director jobs in United States
cer-icon
Apply on Employer Site
company-logo

Exelixis · 2 weeks ago

Senior Business Development Search & Evaluation Director

Exelixis is a biopharmaceutical company focused on the development of innovative cancer therapies. The Senior Business Development Search & Evaluation Director is responsible for sourcing and evaluating external assets for acquisition or partnership, building relationships in the biopharma industry, and collaborating cross-functionally to lead due diligence and assist in transaction negotiations.

BiotechnologyHealth CarePharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Scientific and Market Intelligence: Deep knowledge of Oncology related to current and emerging target landscapes, clinical trial readouts, evolving standards of care, transaction trends, and global market conditions (with a focus on Asia)
Relationship Management: Build and maintain strong external relationships within the biotech/pharmaceutical ecosystem, academic institutions, and investors. Represent Exelixis at scientific and partnering conferences to facilitate the flow of inbound opportunities
Strategy and Planning: Work closely with R&D and commercial leadership to develop and execute Exelixis’ business development strategy
Opportunity Sourcing: Proactively identify and assess external opportunities (assets, platforms, technologies) in Oncology, ensuring alignment with Exelixis’ strategic and scientific priorities
Due Diligence: Lead deep scientific, clinical, and commercial diligence, integrating input from cross-functional experts in R&D, Commercial, and Legal
Presentation & Communication: Synthesize complex scientific information and provide summaries and recommendations for effective decision making. Ensure prompt and clear communication with internal and external stakeholders
Negotiation Support: Work closely with transaction leads and legal teams to develop deal structures and risk mitigation strategies. Support negotiations for licensing, acquisition, and collaboration agreements and ensure timely agreement execution
Working in teams: Maintaining a constructive attitude with internal colleagues and external contacts, while ensuring a focus on teamwork will be key to success

Qualification

Oncology expertiseBusiness developmentDue diligenceRelationship managementStrategic planningNegotiation skillsAnalytical skillsPresentation skillsProject managementInterpersonal skillsCritical thinkingCommunication skills

Required

BA/BS degree in life sciences, biology, biochemistry, pharmacology, oncology or related discipline with 15 years of relevant experience
MA/MS degree in life sciences, biology, biochemistry, pharmacology, oncology or related discipline with 13 years of relevant experience
Ph.D. in life sciences, biology, biochemistry, pharmacology, oncology or related discipline with 12 years of relevant experience
MD in life sciences, biology, biochemistry, pharmacology, oncology or related discipline with 8 years of relevant experience
Equivalent combination of education and years of experience
Minimum of 12 years combined experience in oncology (or related science) and in the biotechnology / pharmaceutical industry
Minimum of 5 years in business development (deal sourcing, scientific assessment, co-leading term sheet and contract negotiations) or related field (e.g. commercial analysis) in a pharmaceutical or biotechnology company or investment bank, venture capital or private equity setting
Established experience in identifying and evaluating partnering opportunities for transactions that have successfully closed
Deep understanding of all aspects of oncology drug development related to discovery, clinical development, regulatory process, IP, CMC, and commercialization
Ability to analyze and synthesize complex scientific, clinical and commercial information to identify key strengths/weaknesses, portfolio fit, risk mitigation strategies and go/no go criteria
Skilled in crafting and presenting summaries with recommendations to ensure effective decision-making
Experience with co-leading term sheet negotiation/contracts for discovery or clinical-stage opportunities
Exceptional oral and written communication, organization, and project management skills
Ability to thrive in a fast-paced, matrix environment
Excellent analytical, critical-thinking, and problem-solving abilities
Strong interpersonal skills to build mutual trust and foster strong relationships internally and externally
Ability to influence without authority and lead effectively
Self-motivated, requiring minimal supervision
Requires an ability to concurrently manage multiple complex projects with tight timelines, while maintaining continuous alignment with multiple stakeholders at different levels, across the organization

Preferred

Postdoctoral experience a plus, but not required
MBA degree is a plus, but not required

Benefits

401k plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
Discretionary annual bonus program
Sales-based incentive plan
Opportunity to purchase company stock
Long-term incentives
15 accrued vacation days in their first year
17 paid holidays including a company-wide winter shutdown in December
Up to 10 sick days throughout the calendar year

Company

Exelixis

company-logo
Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.

H1B Sponsorship

Exelixis has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (39)
2024 (25)
2023 (25)
2022 (28)
2021 (29)
2020 (15)

Funding

Current Stage
Public Company
Total Funding
$514M
Key Investors
Deerfield
2015-07-23Post Ipo Equity· $135M
2012-02-16Post Ipo Equity· $65M
2010-06-03Post Ipo Debt· $160M

Leadership Team

leader-logo
Michael Morrissey
President and CEO
linkedin
leader-logo
Christopher Senner
Executive Vice President and CFO
linkedin
Company data provided by crunchbase